Alar Pharmaceuticals Inc. (6785.TWO)

TWD 122.0

(1.67%)

Operating Expenses Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual operating expenses in 2023 was 83.74 Million TWD , up 76.95% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly operating expenses in 2024 Q2 was 16.94 Million TWD , down -23.36% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a annual operating expenses of 47.32 Million TWD in annual operating expenses 2022, down -49.27% from previous year.
  • Alar Pharmaceuticals Inc. reported a annual operating expenses of 93.29 Million TWD in annual operating expenses 2021, down -45.56% from previous year.
  • Alar Pharmaceuticals Inc. reported a quarterly operating expenses of 22.1 Million TWD for 2024 Q1, down -34.83% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a quarterly operating expenses of 33.92 Million TWD for 2023 Q4, up 136.79% from previous quarter.

Annual Operating Expenses Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Operating Expenses of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 83.74 Million TWD 76.95%
2022 47.32 Million TWD -49.27%
2021 93.29 Million TWD -45.56%
2020 171.36 Million TWD 179.15%
2019 61.38 Million TWD 0.0%

Peer Operating Expenses Comparison of Alar Pharmaceuticals Inc.

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD 46.904%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD 36.932%
Easywell Biomedicals, Inc. 333.45 Million TWD 74.886%
TTY Biopharm Company Limited 1.91 Billion TWD 95.619%
Synmosa Biopharma Corporation 1.49 Billion TWD 94.415%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 96.1%
Center Laboratories, Inc. 697.35 Million TWD 87.991%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD 68.667%
Orient Pharma Co., Ltd. 468.66 Million TWD 82.131%
InnoPharmax Inc. 82.29 Million TWD -1.761%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 65.767%
Excelsior Biopharma Inc. 388.05 Million TWD 78.419%
DV Biomed Co., Ltd. 575.24 Million TWD 85.442%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 92.533%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 79.019%
UniPharma Co., Ltd. 78.32 Million TWD -6.925%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 78.902%
Winston Medical Supply Co., Ltd. 151.49 Million TWD 44.722%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -14046.115%
Bioray Biotech Co., Ltd 96.98 Million TWD 13.649%
TSH Biopharm Corporation Limited 336.26 Million TWD 75.096%